Institutional investors purchased a net $2.6 million shares of ENZ during the quarter ended April 2016, and now own 62.96% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.3 Million shares of Enzo Biochem Inc
MCKINLEY CAPITAL MANAGEMENT LLC Bought 497.3 Thousand shares of Enzo Biochem Inc
SSGA FUNDS MANAGEMENT, INC. Bought 472.3 Thousand shares of Enzo Biochem Inc